Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Obesity | Research

The new visceral adiposity index outperforms traditional obesity indices as a predictor of subclinical renal damage in Chinese individuals: a cross-sectional study

Authors: Yue Sun, Yu Yan, Yueyuan Liao, Chao Chu, Tongshuai Guo, Qiong Ma, Yang Wang, Dan Wang, Hao Jia, Jianjun Mu

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

The new visceral adiposity index (NVAI) was superior to previous obesity indices in predicting cardiovascular diseases among Asians. Nevertheless, the utility of the NVAI for predicting chronic kidney disease is still unclear. The objective of this research was to explore the relationship between the NVAI and subclinical renal damage (SRD) and to investigate whether the NVAI outperforms other common obesity indices in predicting SRD in the Chinese population.

Methods

Participants in this cross-sectional study were from the Hanzhong Adolescent Hypertension Cohort. The NVAI and seven other common obesity indices were calculated, including body mass index, waist circumference, lipid accumulation product, visceral adiposity index, Chinese visceral adiposity index, a body shape index and metabolic score for visceral fat. Logistic regression models revealed the association between NVAI and SRD. The odds ratio (OR) and the 95% confidence interval (CI) were calculated to show the association between the two variables. The predictive power of eight obesity indices for SRD was evaluated through the receiver operating characteristic curve and area under the curve (AUC). In addition, the net reclassification index (NRI) and integrated discrimination improvement (IDI) were also applied to compare the incremental predictive value for SRD of different obesity indices.

Results

The median age of the 2358 subjects was 42.00 years. Across NVAI tertiles, the prevalence of SRD was 7.25%, 11.21%, and 21.60%, respectively. After adjusting for confounders, a high level of NVAI remained a risk factor for SRD. The ORs of the middle and top NVAI tertiles for SRD were 1.920 (95% CI: 1.322, 2.787) and 4.129 (95% CI: 2.750, 6.202), respectively. The AUC of the NVAI was 0.666 (95% CI: 0.647, 0.685), which was significantly larger than the AUC of any of the other obesity indicators. Moreover, the NRI and IDI were significantly improved when NVAI was added to the basic model for predicting SRD. Among eight obesity indices, NVAI had the highest NRI (0.392; 95% CI: 0.280, 0.503), and its IDI (0.021; 95% CI: 0.014, 0.027) was second only to that of the body mass index (0.023; 95% CI: 0.014, 0.032).

Conclusions

NVAI is independently and positively associated with SRD. Among the eight obesity indices, the NVAI shows the strongest predictive power for SRD in the Chinese population. The NVAI may be useful as an effective warning indicator of chronic kidney disease in Chinese adults.
Appendix
Available only for authorised users
Literature
1.
go back to reference Murton M, Goff-Leggett D, Bobrowska A, Garcia Sanchez JJ, James G, Wittbrodt E, et al. Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review. Adv Ther. 2021;38(1):180–200.PubMedCrossRef Murton M, Goff-Leggett D, Bobrowska A, Garcia Sanchez JJ, James G, Wittbrodt E, et al. Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review. Adv Ther. 2021;38(1):180–200.PubMedCrossRef
2.
go back to reference GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.CrossRef GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.CrossRef
3.
go back to reference Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–69.PubMedCrossRef Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–69.PubMedCrossRef
4.
go back to reference Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85(1):49–61.PubMedCrossRef Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85(1):49–61.PubMedCrossRef
5.
go back to reference Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.PubMedCrossRef Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.PubMedCrossRef
6.
go back to reference Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39(3):477–85.PubMedCrossRef Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39(3):477–85.PubMedCrossRef
7.
go back to reference Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, et al. Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant. 2008;23(4):1265–73.PubMedCrossRef Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, et al. Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant. 2008;23(4):1265–73.PubMedCrossRef
8.
go back to reference Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–8.PubMedCrossRef Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–8.PubMedCrossRef
9.
go back to reference Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52(1):29–38.PubMedPubMedCentralCrossRef Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52(1):29–38.PubMedPubMedCentralCrossRef
10.
go back to reference Evans PD, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS ONE. 2012;7(4):e34699.PubMedPubMedCentralCrossRef Evans PD, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS ONE. 2012;7(4):e34699.PubMedPubMedCentralCrossRef
11.
go back to reference Agarwal R, Bills JE, Light RP. Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the “obesity paradox?” Hypertension. 2010;56(5):893–900.PubMedCrossRef Agarwal R, Bills JE, Light RP. Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the “obesity paradox?” Hypertension. 2010;56(5):893–900.PubMedCrossRef
12.
go back to reference Zeng Q, Wang L, Dong S, Zha X, Ran L, Li Y, et al. CT-derived abdominal adiposity: Distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China. Metabolism. 2021;115:154456.PubMedCrossRef Zeng Q, Wang L, Dong S, Zha X, Ran L, Li Y, et al. CT-derived abdominal adiposity: Distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China. Metabolism. 2021;115:154456.PubMedCrossRef
13.
go back to reference Sun K, Lin D, Li F, Qi Y, Feng W, Ren M, et al. Visceral adiposity index is associated with increased urinary albumin excretion: a population-based study. Clin Nutr. 2019;38(3):1332–8.PubMedCrossRef Sun K, Lin D, Li F, Qi Y, Feng W, Ren M, et al. Visceral adiposity index is associated with increased urinary albumin excretion: a population-based study. Clin Nutr. 2019;38(3):1332–8.PubMedCrossRef
14.
go back to reference Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.PubMedPubMedCentralCrossRef Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.PubMedPubMedCentralCrossRef
15.
go back to reference Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214.PubMedPubMedCentralCrossRef Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214.PubMedPubMedCentralCrossRef
16.
go back to reference Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.PubMedPubMedCentralCrossRef Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.PubMedPubMedCentralCrossRef
18.
go back to reference Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Viveros-Ruiz TL, Almeda-Valdes P, Gomez-Velasco D, et al. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020;39(5):1613–21.PubMedCrossRef Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Viveros-Ruiz TL, Almeda-Valdes P, Gomez-Velasco D, et al. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020;39(5):1613–21.PubMedCrossRef
19.
go back to reference Yan P, Xu Y, Miao Y, Tang Q, Wu Y, Bai X, et al. Association of lipid accumulation product with chronic kidney disease in Chinese community adults: a report from the REACTION study. Lipids Health Dis. 2021;20(1):131.PubMedPubMedCentralCrossRef Yan P, Xu Y, Miao Y, Tang Q, Wu Y, Bai X, et al. Association of lipid accumulation product with chronic kidney disease in Chinese community adults: a report from the REACTION study. Lipids Health Dis. 2021;20(1):131.PubMedPubMedCentralCrossRef
20.
go back to reference Chen IJ, Hsu LT, Lu MC, Chen YJ, Tsou MT, Chen JY. Gender differences in the association between obesity indices and chronic kidney disease among middle-aged and elderly Taiwanese population: a community-based cross-sectional study. Front Endocrinol (Lausanne). 2021;12:737586.PubMedCrossRef Chen IJ, Hsu LT, Lu MC, Chen YJ, Tsou MT, Chen JY. Gender differences in the association between obesity indices and chronic kidney disease among middle-aged and elderly Taiwanese population: a community-based cross-sectional study. Front Endocrinol (Lausanne). 2021;12:737586.PubMedCrossRef
21.
go back to reference Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118.PubMedPubMedCentralCrossRef Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118.PubMedPubMedCentralCrossRef
22.
go back to reference Kim B, Kim G, Kim E, Park J, Isobe T, Sakae T, et al. The a body shape index might be a stronger predictor of chronic kidney disease than BMI in a senior population. Int J Environ Res Public Health. 2021;18(24):12874.PubMedPubMedCentralCrossRef Kim B, Kim G, Kim E, Park J, Isobe T, Sakae T, et al. The a body shape index might be a stronger predictor of chronic kidney disease than BMI in a senior population. Int J Environ Res Public Health. 2021;18(24):12874.PubMedPubMedCentralCrossRef
23.
go back to reference Yu P, Meng X, Kan R, Wang Z, Yu X. Association between metabolic scores for visceral fat and chronic kidney disease: a cross-sectional study. Front Endocrinol (Lausanne). 2022;13:1052736.PubMedCrossRef Yu P, Meng X, Kan R, Wang Z, Yu X. Association between metabolic scores for visceral fat and chronic kidney disease: a cross-sectional study. Front Endocrinol (Lausanne). 2022;13:1052736.PubMedCrossRef
24.
go back to reference Oh SK, Cho AR, Kwon YJ, Lee HS, Lee JW. Derivation and validation of a new visceral adiposity index for predicting visceral obesity and cardiometabolic risk in a Korean population. PLoS ONE. 2018;13(9):e0203787.PubMedPubMedCentralCrossRef Oh SK, Cho AR, Kwon YJ, Lee HS, Lee JW. Derivation and validation of a new visceral adiposity index for predicting visceral obesity and cardiometabolic risk in a Korean population. PLoS ONE. 2018;13(9):e0203787.PubMedPubMedCentralCrossRef
25.
go back to reference Son DH, Ha HS, Lee HS, Han D, Choi SY, Chun EJ, et al. Association of the new visceral adiposity index with coronary artery calcification and arterial stiffness in Korean population. Nutr Metab Cardiovasc Dis. 2021;31(6):1774–81.PubMedCrossRef Son DH, Ha HS, Lee HS, Han D, Choi SY, Chun EJ, et al. Association of the new visceral adiposity index with coronary artery calcification and arterial stiffness in Korean population. Nutr Metab Cardiovasc Dis. 2021;31(6):1774–81.PubMedCrossRef
26.
go back to reference Zheng W, Mu J, Chu C, Hu J, Yan Y, Ma Q, et al. Association of blood pressure trajectories in early life with subclinical renal damage in middle age. J Am Soc Nephrol. 2018;29(12):2835–46.PubMedPubMedCentralCrossRef Zheng W, Mu J, Chu C, Hu J, Yan Y, Ma Q, et al. Association of blood pressure trajectories in early life with subclinical renal damage in middle age. J Am Soc Nephrol. 2018;29(12):2835–46.PubMedPubMedCentralCrossRef
28.
go back to reference Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22.PubMedCrossRef Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22.PubMedCrossRef
29.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.PubMedCrossRef Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.PubMedCrossRef
30.
go back to reference Mulè G, Calcaterra I, Costanzo M, Geraci G, Guarino L, Foraci AC, et al. Relationship between short-term blood pressure variability and subclinical renal damage in essential hypertensive patients. J Clin Hypertens (Greenwich). 2015;17(6):473–80.PubMedCrossRef Mulè G, Calcaterra I, Costanzo M, Geraci G, Guarino L, Foraci AC, et al. Relationship between short-term blood pressure variability and subclinical renal damage in essential hypertensive patients. J Clin Hypertens (Greenwich). 2015;17(6):473–80.PubMedCrossRef
31.
go back to reference Leoncini G, Viazzi F, Conti N, Baratto E, Tomolillo C, Bezante GP, et al. Renal and cardiac abnormalities in primary hypertension. J Hypertens. 2009;27(5):1064–73.PubMedCrossRef Leoncini G, Viazzi F, Conti N, Baratto E, Tomolillo C, Bezante GP, et al. Renal and cardiac abnormalities in primary hypertension. J Hypertens. 2009;27(5):1064–73.PubMedCrossRef
32.
go back to reference Bragina A, Osadchiy KK, Rodionova JN, Bayutina D, Cherepanov AG, Podzolkov VI. Pararenal fat and renal dysfunction in patients without significant cardiovascular disease. Am J Nephrol. 2022;53(5):416–22.PubMedCrossRef Bragina A, Osadchiy KK, Rodionova JN, Bayutina D, Cherepanov AG, Podzolkov VI. Pararenal fat and renal dysfunction in patients without significant cardiovascular disease. Am J Nephrol. 2022;53(5):416–22.PubMedCrossRef
33.
go back to reference Olivero A, Basso L, Barabino E, Milintenda P, Testino N, Chierigo F, et al. The impact of visceral adipose tissue on postoperative renal function after radical nephrectomy for renal cell carcinoma. Minerva Urol Nephrol. 2021;73(6):789–95.PubMed Olivero A, Basso L, Barabino E, Milintenda P, Testino N, Chierigo F, et al. The impact of visceral adipose tissue on postoperative renal function after radical nephrectomy for renal cell carcinoma. Minerva Urol Nephrol. 2021;73(6):789–95.PubMed
34.
go back to reference Shi Y, Hu L, Li M, Zhou W, Wang T, Zhu L, et al. Association between the surrogate markers of insulin resistance and chronic kidney disease in Chinese hypertensive patients. Front Med (Lausanne). 2022;9:831648.PubMedCrossRef Shi Y, Hu L, Li M, Zhou W, Wang T, Zhu L, et al. Association between the surrogate markers of insulin resistance and chronic kidney disease in Chinese hypertensive patients. Front Med (Lausanne). 2022;9:831648.PubMedCrossRef
35.
go back to reference Mei X, Hu S, Mi L, Zhou Y, Chen T. Body mass index and all-cause mortality in patients with percutaneous coronary intervention: a dose-response meta-analysis of obesity paradox. Obes Rev. 2021;22(2):e13107.PubMedCrossRef Mei X, Hu S, Mi L, Zhou Y, Chen T. Body mass index and all-cause mortality in patients with percutaneous coronary intervention: a dose-response meta-analysis of obesity paradox. Obes Rev. 2021;22(2):e13107.PubMedCrossRef
36.
go back to reference Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81(3):543–54.PubMedCrossRef Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81(3):543–54.PubMedCrossRef
37.
go back to reference Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis. 2007;49(5):581–91.PubMedCrossRef Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis. 2007;49(5):581–91.PubMedCrossRef
38.
go back to reference Pou KM, Massaro JM, Hoffmann U, Lieb K, Vasan RS, O’Donnell CJ, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care. 2009;32(3):481–5.PubMedPubMedCentralCrossRef Pou KM, Massaro JM, Hoffmann U, Lieb K, Vasan RS, O’Donnell CJ, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care. 2009;32(3):481–5.PubMedPubMedCentralCrossRef
39.
go back to reference Parente EB, Mutter S, Harjutsalo V, Ahola AJ, Forsblom C, Groop PH. Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes. Sci Rep. 2020;10:18575.PubMedPubMedCentralCrossRef Parente EB, Mutter S, Harjutsalo V, Ahola AJ, Forsblom C, Groop PH. Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes. Sci Rep. 2020;10:18575.PubMedPubMedCentralCrossRef
40.
go back to reference Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22(12):1164–71.PubMedCrossRef Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22(12):1164–71.PubMedCrossRef
41.
go back to reference Lin M, Li N, Heizhati M, Gan L, Zhu Q, Yao L, et al. Chinese visceral adiposity index is associated with incident renal damage in patients with hypertension and abnormal glucose metabolism: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:910329.PubMedCrossRef Lin M, Li N, Heizhati M, Gan L, Zhu Q, Yao L, et al. Chinese visceral adiposity index is associated with incident renal damage in patients with hypertension and abnormal glucose metabolism: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:910329.PubMedCrossRef
42.
go back to reference Feng L, Chen T, Wang X, Xiong C, Chen J, Wu S, et al. Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk. Diabetes Metab Syndr Obes. 2022;15:2249–58.PubMedPubMedCentralCrossRef Feng L, Chen T, Wang X, Xiong C, Chen J, Wu S, et al. Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk. Diabetes Metab Syndr Obes. 2022;15:2249–58.PubMedPubMedCentralCrossRef
43.
go back to reference Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15(6):367–85.PubMedPubMedCentralCrossRef Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15(6):367–85.PubMedPubMedCentralCrossRef
44.
go back to reference de Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417–26.PubMedCrossRef de Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417–26.PubMedCrossRef
46.
go back to reference Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2(8311):1309–11.PubMedCrossRef Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2(8311):1309–11.PubMedCrossRef
47.
go back to reference Stasi A, Cosola C, Caggiano G, Cimmarusti MT, Palieri R, Acquaviva PM, et al. Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management. Front Nutr. 2022;9:925619.PubMedPubMedCentralCrossRef Stasi A, Cosola C, Caggiano G, Cimmarusti MT, Palieri R, Acquaviva PM, et al. Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management. Front Nutr. 2022;9:925619.PubMedPubMedCentralCrossRef
Metadata
Title
The new visceral adiposity index outperforms traditional obesity indices as a predictor of subclinical renal damage in Chinese individuals: a cross-sectional study
Authors
Yue Sun
Yu Yan
Yueyuan Liao
Chao Chu
Tongshuai Guo
Qiong Ma
Yang Wang
Dan Wang
Hao Jia
Jianjun Mu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01330-5

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.